EUVIMEDEUVIMED entdecken
Crossref

Bacteriocin dynamics in Enterococcus faecium and Enterococcus lactis: implications for clinical and commensal strain interactions

Ana C. Almeida-Santos, Ana P. Tedim, Bárbara Duarte, Michael Brilhante, Coque, Teresa M., Novais, Carla, Freitas, Ana R., Peixe, Luísa

Science Letters · 23.04.2024

DOI: 10.48797/sl.2024.131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Letters, erschienen am 23.04.2024. Verfasst von Ana C. Almeida-Santos und 11 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Enterococcus faecium-Efm and E.lactis-Elts (former Efm-cladeB) colonize the human gut, with Efm also being a leading hospital-pathogen. Dynamics influencing strain dominance in competitive environments (e.g., infection/colonization) are not fully understood, but bacteriocins may provide competitive advantage to clinical Efm or commensal Elts strains.

Objective

We explored bacteriocin content of contemporary Efm and Elts, isolated from healthy/diseased humans, and correlated it with their inhibition profiles against strains across these species.

Methods

A collection of 129 strains [91 clinical-Efm (77 vancomycin-resistant-VRE); 35 healthy-volunteers (21-Efm;14-Elts)] from 1996-2022 were challenged against each other by a qualitative bacteriocin production/sensitivity-assay (soft-agar-overlay-technique). Eighty-eight representatives were sequenced (Illumina-NovaSeq) to establish clonality, antibiotic profiles (CGE-tool), and bacteriocins (homemade-database) [1].

Results

Elts (93%) and Efm (87%) carried ≥ 1 bacteriocin. Twenty-one bacteriocins were found, including 8 newly identified. Efm exhibited greater diversity (1-9; x̄=3.6 vs 1-5; x̄=2.6) and both species presented exclusive bacteriocin genes (Efm:bac43/AS5/AS9/enxA/B/entB; Elts:entL50A/B/GM-1). Bacteriocins 43/AS5/AS11/AS9/entA were significantly associated with clinical-Efm-strains (p

Schlagwörter

Enterococcus faeciumEnterococcus lactisbacteriocinsclinical isolatescommensal strainsintestinal colonizationvancomycin-resistant Enterococcus faeciumstrain dominanceST117ST78

Zitieren

APA

Almeida-Santos, A. C., Tedim, A. P., Duarte, B., Brilhante, M., Coque, M., T., Novais, Carla, Freitas, R., A., Peixe, & Luísa (2024). Bacteriocin dynamics in Enterococcus faecium and Enterococcus lactis: implications for clinical and commensal strain interactions. Science Letters. https://doi.org/10.48797/sl.2024.131

Vancouver

Almeida-Santos AC, Tedim AP, Duarte B, Brilhante M, Coque, M. T, et al. Bacteriocin dynamics in Enterococcus faecium and Enterococcus lactis: implications for clinical and commensal strain interactions. Science Letters. 2024. doi:10.48797/sl.2024.131

BibTeX
@article{AlmeidaSantos2024,
  author = {Almeida-Santos, Ana C. and Tedim, Ana P. and Duarte, Bárbara and Brilhante, Michael and Coque and M., Teresa and Novais and Carla and Freitas and R., Ana and Peixe and Luísa},
  title = {Bacteriocin dynamics in Enterococcus faecium and Enterococcus lactis: implications for clinical and commensal strain interactions},
  journal = {Science Letters},
  year = {2024},
  doi = {10.48797/sl.2024.131}
}
Kostenlos starten →